The Association Between Branched-Chain Amino Acid Concentrations and the Risk of Autism Spectrum Disorder in Preschool-Aged Children
Open Access
- 24 January 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (8) , 6031-6044
Abstract
Several studies have linked branched-chain amino acid (BCAA) metabolism disorders with autism spectrum disorder (ASD), but the results have been inconsistent. The purpose of this study was to explore the association between BCAA concentrations and the risk of ASD. A total of 313 participants were recruited from two tertiary referral hospitals from May 2018 to July 2021. Concentrations of BCAAs in dried blood spots were analyzed using liquid chromatography-tandem mass spectrometry-based analysis. Multivariate analyses and restricted cubic spline models were used to identify the association between BCAAs and the risk of ASD, and a nomogram was developed by using multivariate logistic regression and the risk was determined by receiver operating characteristic curve analysis and calibration curve analysis. Concentrations of total BCAA, valine, and leucine/isoleucine were higher in the ASD group, and all of them were positively and non-linearly associated with the risk of ASD even after adjusting for potential confounding factors such as age, gender, body mass index, and concentrations of BCAAs (P < 0.05). The nomogram integrating total BCAA and valine showed a good discriminant AUC value of 0.756 (95% CI 0.676–0.835). The model could yield net benefits across a reasonable range of risk thresholds. In the stratified analysis, the diagnostic ability of the model was more pronounced in children older than 3 years. We provide evidence that increased levels of BCAAs are associated with the risk of ASD, and the nomogram model of BCAAs presented here can serve as a marker for the early diagnosis of ASD.Keywords
Funding Information
- University of Gothenburg
This publication has 33 references indexed in Scilit:
- Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum DisorderCell, 2016
- Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literatureAmino Acids, 2016
- The use of mass spectrometry to analyze dried blood spotsMass Spectrometry Reviews, 2014
- Branched-chain amino acids alter neurobehavioral function in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2013
- Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placeboTranslational Psychiatry, 2013
- Chronic administration of branched‐chain amino acids impairs spatial memory and increases brain‐derived neurotrophic factor in a rat modelJournal of Inherited Metabolic Disease, 2012
- Expression of mitochondrial branched-chain aminotransferase and α-keto-acid dehydrogenase in rat brain: implications for neurotransmitter metabolismFrontiers in Neuroanatomy, 2012
- Distinct Plasma Profile of Polar Neutral Amino Acids, Leucine, and Glutamate in Children with Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2011
- Reduced Astrocytic Contribution to the Turnover of Glutamate, Glutamine, and GABA Characterizes the Latent Phase in the Kainate Model of Temporal Lobe EpilepsyJournal of Cerebral Blood Flow & Metabolism, 2011
- Dual mechanism of brain injury and novel treatment strategy in maple syrup urine diseaseBrain, 2008